Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy.

Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG.

AIDS. 2009 Oct 23;23(16):2143-9. doi: 10.1097/QAD.0b013e3283313c91.

2.

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM.

AIDS. 2012 Sep 24;26(15):1907-15.

3.

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM.

AIDS. 2008 Feb 19;22(4):481-7. doi: 10.1097/QAD.0b013e3282f4706d.

4.

HIV viremia and changes in kidney function.

Longenecker CT, Scherzer R, Bacchetti P, Lewis CE, Grunfeld C, Shlipak MG.

AIDS. 2009 Jun 1;23(9):1089-96. doi: 10.1097/QAD.0b013e32832a3f24.

5.

Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.

Longo AL, Lepira FB, Sumaili EK, Makulo JR, Mukumbi H, Bukabau JB, Mokoli VM, Kayembe PK, Nseka NM.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):59-64. doi: 10.1097/QAI.0b013e31823587b0.

PMID:
21926635
6.

Antiretroviral therapy-induced changes in plasma lipids and the risk of kidney dysfunction in HIV-infected men.

Abraham AG, Li X, Jacobson LP, Estrella MM, Evans RW, Witt MD, Phair J.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1346-52. doi: 10.1089/AID.2012.0253.

7.

Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.

Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG.

Am J Kidney Dis. 2012 May;59(5):628-35. doi: 10.1053/j.ajkd.2011.10.050.

8.

The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.

Estrella MM, Li M, Tin A, Abraham AG, Shlipak MG, Penugonda S, Hussain SK, Palella FJ Jr, Wolinsky SM, Martinson JJ, Parekh RS, Kao WH.

Clin Infect Dis. 2015 Feb 15;60(4):646-52. doi: 10.1093/cid/ciu765.

9.

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.

Stöhr W, Reid A, Walker AS, Ssali F, Munderi P, Mambule I, Kityo C, Grosskurth H, Gilks CF, Gibb DM, Hakim J; DART Trial Team..

Antivir Ther. 2011;16(7):1011-20. doi: 10.3851/IMP1832.

PMID:
22024517
10.
11.

Comparative analysis of the new chronic kidney disease epidemiology collaboration and the modification of diet in renal disease equations for estimation of glomerular filtration rate in HIV type 1-infected subjects.

Dabrowska MM, Mikula T, Stanczak W, Malyszko J, Wiercinska-Drapalo A.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):809-13. doi: 10.1089/AID.2010.0233.

PMID:
21284524
12.

Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.

Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, Szczech L.

Am J Kidney Dis. 2009 Jul;54(1):43-50. doi: 10.1053/j.ajkd.2009.02.009.

13.

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration..

Lancet. 2004 Jul 3-9;364(9428):51-62.

PMID:
15234856
14.

Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.

Wensink GE, Schoffelen AF, Tempelman HA, Rookmaaker MB, Hoepelman AI, Barth RE.

PLoS One. 2015 Aug 26;10(8):e0136529. doi: 10.1371/journal.pone.0136529.

15.

Kidney function and the risk of cardiovascular events in HIV-1-infected patients.

George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG.

AIDS. 2010 Jan 28;24(3):387-94. doi: 10.1097/QAD.0b013e3283359253.

17.

No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.

Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J.

HIV Med. 2013 Jul;14(6):362-9. doi: 10.1111/hiv.12016.

18.

Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.

Kamkuemah M, Kaplan R, Bekker LG, Little F, Myer L.

Trop Med Int Health. 2015 Apr;20(4):518-26. doi: 10.1111/tmi.12446.

19.

Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.

Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.

Scand J Infect Dis. 2012 Sep;44(9):689-96. doi: 10.3109/00365548.2012.673730.

PMID:
22680981
20.

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN.

AIDS. 2003 Sep 5;17(13):1907-15.

PMID:
12960823

Supplemental Content

Support Center